Literature DB >> 3699893

Influence of body temperature on bacterial growth rates in experimental pneumococcal meningitis in rabbits.

P M Small, M G Täuber, C J Hackbarth, M A Sande.   

Abstract

We examined the role of fever as a host defense in experimental pneumococcal meningitis in rabbits. Twelve hours after intracisternal inoculation of an encapsulated type 3 Streptococcus pneumoniae strain, body temperature was manipulated by using two different anesthetic drugs: pentobarbital, which did not affect temperature, and urethane, which mitigated the febrile response to infection. Growth rates of pneumococci in cerebrospinal fluid were dramatically influenced by modification of the febrile response. Rabbits whose fever was not suppressed had mean bacterial doubling times of 2.76 +/- 1.43 h. Animals with a blunted febrile response had a significantly faster mean bacterial growth rate (doubling time = 1.10 +/- 0.27 h; P less than 0.02). When the antipyretic effect of urethane was counteracted by raising the ambient temperature, animals also showed a marked reduction in pneumococcal growth rates. In vitro, the pneumococci grew well at 37 degrees C in Trypticase soy broth (doubling time = 0.61 +/- 0.05 h) and in pooled rabbit cerebrospinal fluid (doubling time = 0.85 +/- 0.07 h). However, at 41 degrees C neither medium supported growth. Thus, body temperature appears to be a critical determinant of pneumococcal growth rates in experimental meningitis, and fever could be a host defense in this disease.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3699893      PMCID: PMC261024          DOI: 10.1128/iai.52.2.484-487.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  17 in total

1.  Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis.

Authors:  W E Feldman
Journal:  N Engl J Med       Date:  1977-02-24       Impact factor: 91.245

2.  Fever as a mechanism of resistance.

Authors:  I L BENNETT; A NICASTRI
Journal:  Bacteriol Rev       Date:  1960-03

3.  Clearance of bacteria from cerebrospinal fluid to blood in experimental meningitis.

Authors:  W M Scheld; T S Park; R G Dacey; H R Winn; J A Jane; M A Sande
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

4.  Survival value of fever in fish.

Authors:  J B Covert; W W Reynolds
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

Review 5.  The role of regional body temperature in the pathogenesis of disease.

Authors:  D Rodbard
Journal:  N Engl J Med       Date:  1981-10-01       Impact factor: 91.245

6.  Fever and survival.

Authors:  M J Kluger; D H Ringler; M R Anver
Journal:  Science       Date:  1975-04-11       Impact factor: 47.728

7.  Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives.

Authors:  R G Dacey; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

8.  Experimental pneumococcal meningitis: role of leukocytes in pathogenesis.

Authors:  J D Ernst; J M Decazes; M A Sande
Journal:  Infect Immun       Date:  1983-07       Impact factor: 3.441

Review 9.  Bacterial meningitis--1982.

Authors:  R Gold
Journal:  Am J Med       Date:  1983-07-28       Impact factor: 4.965

10.  Effects of fever on host defense mechanisms after infection in the lizard Dipsosaurus dorsalis.

Authors:  H A Bernheim; P T Bodel; P W Askenase; E Atkins
Journal:  Br J Exp Pathol       Date:  1978-02
View more
  24 in total

Review 1.  Influence of growth rate on susceptibility to antimicrobial agents: modification of the cell envelope and batch and continuous culture studies.

Authors:  M R Brown; P J Collier; P Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 2.  Cordelia, Goneril and the febrile response.

Authors:  P A Mackowiak
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

3.  Influence of antibiotic dose, dosing interval, and duration of therapy on outcome in experimental pneumococcal meningitis in rabbits.

Authors:  M G Täuber; S Kunz; O Zak; M A Sande
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

Review 4.  Bacterial meningitis: current controversies in approaches to treatment.

Authors:  A J Williams; S Nadel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

5.  Elevated body temperature restricts growth of Haemophilus influenzae type b during experimental meningitis.

Authors:  T O'Reilly; O Zak
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

6.  Management of fever and neutropenia in children with cancer.

Authors:  A Vedi; V Pennington; M O'Meara; K Stark; A Senner; P Hunstead; K Adnum; W Londall; L Maurice; Claire Wakefield; R J Cohn
Journal:  Support Care Cancer       Date:  2014-12-23       Impact factor: 3.603

7.  Modulation of brain injury as a target of adjunctive therapy in bacterial meningitis.

Authors:  Uwe Koedel; Matthias Klein; Hans-Walter Pfister
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

Review 8.  Acute bacterial meningitis in infants and children: epidemiology and management.

Authors:  Shruti Agrawal; Simon Nadel
Journal:  Paediatr Drugs       Date:  2011-12-01       Impact factor: 3.022

Review 9.  Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Authors:  R Nau; F Sörgel; H W Prange
Journal:  Clin Pharmacokinet       Date:  1998-09       Impact factor: 6.447

10.  A novel id-iri score: development and internal validation of the multivariable community acquired sepsis clinical risk prediction model.

Authors:  Husrev Diktas; Serhat Uysal; Hakan Erdem; Yasemin Cag; Egidia Miftode; Gul Durmus; Ayşegul Ulu-Kilic; Selma Alabay; Balint Gergely Szabo; Botond Lakatos; Ricardo Fernandez; Pinar Korkmaz; Michael Cruz Caliz; Xavier Argemi; Sholpan Kulzhanova; Fatime Kormaz; Fatma Yilmaz-Karadag; Pinar Ergen; Aynur Atilla; Edmond Puca; Mustafa Dogan; Francesca Mangani; Suzan Sahin; Svjetlana Grgić; Krsto Grozdanovski; Gul Ruhsar Yilmaz; Rosa Fontana Del-Vecchio; Aslihan Demirel; Fatma Sirmatel; Alper Şener; Suzan Sacar; Emsal Aydin; Ayşe Batirel; Gorana Dragovac; Rehab El-Sokkary; Crişan Alexandru; Selcan Arslan-Ozel; Sibel Bolukcu; H Deniz Ozkaya; Saygin Nayman-Alpat; Asuman Inan; Fahad Al-Majid; Berna Kaya-Ugur; Jordi Rello
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-10       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.